Bindoclav
(2R,3Z,5R)-3-(2-Hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 5280980.
Registration
- Applicants
- 2
- Registrations
- 5
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Cipla Medpro (Pty) Ltd | Bindoclav | 375 mg, 625 mg, 1000 mg | 410532, 410533, 410534 | Not determined | None |
| Aurogen South Africa (Pty) Ltd | Bindoclav | 31,25 mg/5 ml 125-, 62,5 mg/5 ml 250- | 410965, 410966 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Bindoclav 375 MG EACH TABLET CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 250,0 mgPOTASSIUM CLAVULANATE EQUIVALENT TO CLAVULANIC ACID 125,0 mg | 375 mg | 41053241/20.1.2/0532 | Registered | Not determined | None |
| Bindoclav 625 MG EACH TABLET CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 500,0 mgPOTASSIUM CLAVULANATE EQUIVALENT TO CLAVULANIC ACID 125,0 mg | 625 mg | 41053341/20.1.2/0533 | Registered | Not determined | None |
| Bindoclav 1000 MG EACH TABLET CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 875,0 mgPOTASSIUM CLAVULANATE EQUIVALENT TO CLAVULANIC ACID 125,0 mg | 1000 mg | 41053441/20.1.2/0534 | Registered | Not determined | None |
| Bindoclav suspension 125-31,25 mg/5 ML EACH 5,0 ml SUSPENSION CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 125,0 mg POTASSIUM CLAVULANATE EQUIVALENT TO CLAVULANIC ACID 31,25 mg | 31,25 mg/5 ml 125-Suspension | 41096541/20.1.2/0965 | Registered | Not determined | None |
| Bindoclav suspension 250-62,5 mg/5 ML EACH 5,0 ml SUSPENSION CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 250,0 mg POTASSIUM CLAVULANATE EQUIVALENT TO CLAVULANIC ACID 62,5 mg | 62,5 mg/5 ml 250-Suspension | 41096641/20.1.2/0966 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Amoxicillin
Consolidated Schedules 06 July 2026, line 5238
S4: Clavulanic acid
Consolidated Schedules 06 July 2026, line 5829
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.